Lenalidomide, dexamethasone

DRUG4 trials

Sponsors

Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH, Fondazione EMN Italy Onlus, IRCCS Centro di Riferimento Oncologico della Basilicata, Peking Union Medical College Hospital

Conditions

Multiple MyelomaPOEMS SyndromePrimary Plasma Cell Leukemia

Phase 2

Lenalidomide and Dexamethasone in Primary Plasma Cell Leukemia

CompletedNCT01553357

IRCCS Centro di Riferimento Oncologico della BasilicataPrimary Plasma Cell Leukemia

Start: 2009-03-31End: 2011-09-30Updated: 2012-03-14

Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome

CompletedNCT01816620

Peking Union Medical College HospitalPOEMS Syndrome

Start: 2014-03-31End: 2017-04-30Updated: 2017-04-25

Phase 3

Combination of Lenalidomide and Dexamethasone in Treatment of Multiple Myeloma

CompletedNCT01090089

Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbHMultiple Myeloma

Start: 2010-03-01End: 2020-01-31Updated: 2023-02-23

Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients

CompletedNCT01093196

Fondazione EMN Italy OnlusMultiple Myeloma

Start: 2009-10-31End: 2024-07-01Updated: 2024-11-07

Related Papers

Personalized prognostic model for multiple myeloma patients using continuous variables

Blood2025-11-03

Skin Responses in Newly Diagnosed Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome After Therapy With Low-Dose Lenalidomide Plus Dexamethasone

Frontiers in Immunology2021-05-066 citations

Reliability of optic disc edema area in estimating the severity of papilledema in patients with POEMS syndrome.

2020-05-192 citations

Predictive Model of Early Relapse in Newly Diagnosed Multiple Myeloma: Analysis from a Pooled Dataset

Blood2019-11-132 citations

Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial

Haematologica2019-10-0343 citations

First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials

Haematologica2019-06-2717 citations

Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs.

2019-06-2047 citations

Outcome of Soft-Tissue Plasmocytomas in Newly Diagnosed Multiple Myeloma Patients Treated with New Drugs

Blood2018-11-29

A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome

American Journal of Hematology2018-03-3169 citations

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma

Blood2016-01-0494 citations

A Prospective Phase II Study of Combination of Low Dose Lenalidomide and Dexamethasone for Patients with Newly Diagnosed POEMS Syndrome

Blood2015-12-032 citations